Fol. Biol. 2005, 51, 114-120
https://doi.org/10.14712/fb2005051040114
Molecular Therapeutics Lessons from the Role of Src in Cellular Signalling
References
1. , J. D., Jakymiw, A., Fujita, D. J. (2000) Selected glimpses into the activation and function of Src kinase. Oncogene 19, 5620-5635.
<https://doi.org/10.1038/sj.onc.1203923>
2. , R. A., Broome, M. A., Liu, X., Wu, J., Gishizky, M., Sun, L., Courtneidge, S. A. (2000) SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell Biol. 20, 9018-9027.
<https://doi.org/10.1128/MCB.20.23.9018-9027.2000>
3. , P., Hunter, T. (2001) Oncogenic kinase signalling. Nature 411, 355-365.
<https://doi.org/10.1038/35077225>
4. , T. J., Eck, M. J. (2004) Structure and regulation of Src family kinases. Oncogene 23, 7918-7927.
<https://doi.org/10.1038/sj.onc.1208081>
5. , V., Scott, M. P., Ribon, V., Sherman, L., Anderson, S. M., Maller, J. L., Miller, W. T., Edwards, D. P. (2001) Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 8, 269-280.
<https://doi.org/10.1016/S1097-2765(01)00304-5>
6. , J., Constancio, S. S., Shin, N. Y., Pozzi, A., Weaver, A. M., Hanks, S. K. (2004) CAS promotes invasiveness of Src-transformed cells. Oncogene 23, 406-415.
<https://doi.org/10.1038/sj.onc.1207965>
7. , P. A., Korkaya, H., Courtneidge, S. A. (2004) The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23, 7957-7968.
<https://doi.org/10.1038/sj.onc.1208079>
8. , S., Moro, L., Baj, G., Smeriglio, M., Di Stefano, P., Gippone, S., Surico, N., Silengo, L., Turco, E., Tarone, G., Defilippi, P. (2004) p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells. J. Cell. Sci. 117, 1603-1611.
<https://doi.org/10.1242/jcs.01025>
9. , A. C. (2004) TOR signaling in mammals. J. Cell. Sci. 117, 4615-4616.
<https://doi.org/10.1242/jcs.01311>
10. , M. L., Coudry, J., Chang, W. C. (2004) beta-cateninmediated signaling: a molecular target for early chemopreventive intervention. Mutat. Res. 555, 97-105.
<https://doi.org/10.1016/j.mrfmmm.2004.05.021>
11. , G. M., Roskoski, R. Jr. (1984) Tyrosyl and cyclic AMP-dependent protein kinase activities in BHK cells that express viral pp60src . Mol. Cell. Biol. 4, 973-977.
12. , A., Harris, A. L. (1999) eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Cell Biol. 31, 59-72.
<https://doi.org/10.1016/S1357-2725(98)00132-0>
13. , A., Thomas, G. (1999) Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253, 100-109.
<https://doi.org/10.1006/excr.1999.4683>
14. , G., Shumay, E., Malbon, C. C., Wang, H. (2001) c-Src tyrosine kinase binds the beta 2-adrenergic receptor via phospho-Tyr-350, phosphorylates G-protein-linked receptor kinase 2, and mediates agonist-induced receptor desensitization. J. Biol. Chem. 276, 13240-13247.
<https://doi.org/10.1074/jbc.M011578200>
15. , M. C. (2002) Src in cancer: deregulation and consequences for cell behaviour. Biochim. Biophys. Acta 1602, 114-130.
16. , M. C., Fincham, V. J., Carragher, N. O., Wyke, J. A. (2002) v-Srcës hold over actin and cell adhesions. Nat. Rev. Mol. Cell Biol. 3, 233-245.
<https://doi.org/10.1038/nrm779>
17. , C. (2004) Oncogenic tyrosine kinases. Cell. Mol. Life Sci. 61, 2895-2896.
<https://doi.org/10.1007/s00018-004-4270-1>
18. , T., Shipitsin, M., Lu, Z., Foster, D. A., Klinz, S. G., Feig, L. A. (2000) An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity. EMBO J. 19, 623-630.
<https://doi.org/10.1093/emboj/19.4.623>
19. , V. M., Gross, S., Kaur, A. S., Wilson, R. I., Xu, L. H., Yang, X. H., Cance, W. G. (2003) Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. Mol. Cancer Res. 1, 755-764.
20. , Y., Hsu, Y. S., Martin, G. S. (2000) Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt. Oncogene 19, 3164-3171.
<https://doi.org/10.1038/sj.onc.1203655>
21. , M., Rowinsky, E. K. (2000) The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19, 6680-6686.
<https://doi.org/10.1038/sj.onc.1204091>
22. , E. C., Sonenberg, N., Pandolfi, P. P., Thomas, G. (2004) Signaling control of mRNA translation in cancer pathogenesis. Oncogene 23, 3138-3144.
<https://doi.org/10.1038/sj.onc.1207590>
23. , R. B., Mao, W., Coppola, D., Kang, J., Loubeau, J. M., Trudeau, W., Karl, R., Fujita, D. J., Jove, R., Yeatman, T. J. (1999) Activating SRC mutation in a subset of advanced human colon cancers. Nat. Genet. 21, 187-190.
<https://doi.org/10.1038/5971>
24. , A. V., Rosen, J. M. (2001) Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells. Cell Growth Differ. 12, 1-7.
25. , C. A. (2004) Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word? Mol. Endocrinol. 18, 269-278.
<https://doi.org/10.1210/me.2003-0331>
26. , M., Kim, J. Y., Anderson, W. B. (2004) Src tyrosine kinase inhibitor PP2 markedly enhances Ras-independent activation of Raf-1 protein kinase by phorbol myristate acetate and H2O2. J. Biol. Chem. 279, 48692-48701.
<https://doi.org/10.1074/jbc.M403132200>
27. , D. K., Luttrell, L. M. (2004) Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene 23, 7969-7978.
<https://doi.org/10.1038/sj.onc.1208162>
28. , Y. C., Huang, X. Y. (2002) Novel regulation and function of Src tyrosine kinase. Cell. Mol. Life Sci. 59, 456-462.
<https://doi.org/10.1007/s00018-002-8438-2>
29. , G. S. (2004) The road to Src. Oncogene 23, 7910-7917.
<https://doi.org/10.1038/sj.onc.1208077>
30. , T., Kiguchi, K., Jiang, J., Carbajal, S., Ruffino, L., Beltrán, L., Wang, X. J., Roop, D. R., DiGiovanni, J. (2004) Development of transgenic mice inducibly express an active form of c-Src in the epidermis. Mol. Carcinog. 40, 189-200.
<https://doi.org/10.1002/mc.20027>
31. , G. W., Fincham, V. J., Frame, M. C. (2000) v-Src induces tyrosine phosphorylation of focal adhesion kinase independently of tyrosine 397 and formation of a complex with Src. J. Biol. Chem. 275, 23333-23339.
<https://doi.org/10.1074/jbc.M909322199>
32. , J., Matsumura, I., Sonoyama, J., Daino, H., Kawasaki, A., Tanaka, H., Inohara, N., Kitamura, T., Downward, J., Nakajima, K., Hirano, T., Kanakura, Y. (2000) Full oncogenic activities of v-Src are mediated by multiple signaling pathways. Ras as an essential mediator for cell survival. J. Biol. Chem. 275, 24096-24105.
<https://doi.org/10.1074/jbc.M001606200>
33. , D. W., McLean, G. W., Wyke, A. W., Paraskeva, C., Parkinson, E. K., Frame, M. C., Brunton, V. G. (2000) The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol. Biol. Cell 11, 51-64.
<https://doi.org/10.1091/mbc.11.1.51>
34. , T. (2004) Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116, 191-203.
<https://doi.org/10.1016/S0092-8674(03)01077-8>
35. , E., Martin, G. S. (1999) Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol. Biol. Cell 10, 1693-1703.
<https://doi.org/10.1091/mbc.10.6.1693>
36. , A. B., Roczniak-Ferguson, A. (2004) Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene 23, 7947-7956.
<https://doi.org/10.1038/sj.onc.1208161>
37. , S., Koegl, M., Barone, M. V., Roussel, M. F., Courtneidge, S. A. (1995) DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases. Mol. Cell Biol. 15, 1102-1109.
<https://doi.org/10.1128/MCB.15.2.1102>
38. , R., Jr. (2004) Src protein-tyrosine kinase structure and regulation. Biochem. Biophys. Res. Commun. 324, 1155-1164.
<https://doi.org/10.1016/j.bbrc.2004.09.171>
39. , D., Pandolfi, P. P. (2003) Does the ribosome translate cancer? Nat. Rev. Cancer 3, 179-192.
<https://doi.org/10.1038/nrc1015>
40. , R., Iwamatsu, A., Hirano, N., Ogawa, S., Tanaka, T., Mano, H., Yazaki, Y., Hirai, H. (1994) A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13, 3748-3756.
<https://doi.org/10.1002/j.1460-2075.1994.tb06684.x>
41. , L., Ramos-Nino, M. E., Martinelli, M., Mossman, B. T. (2004) Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos. Oncogene 23, 805-813.
<https://doi.org/10.1038/sj.onc.1207163>
42. , A. N., Tiruppathi, C., Smrcka, A. V., Malik, A. B., Minshall, R. D. (2004) Gbetagamma activation of Src induces caveolae-mediated endocytosis in endothelial cells. J. Biol. Chem. 279, 48055-48062.
<https://doi.org/10.1074/jbc.M405837200>
43. , M. A. (2004) Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation. Oncogene 23, 7979-7989.
<https://doi.org/10.1038/sj.onc.1208076>
44. , C. M. (2004) Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 23, 8017-8023.
<https://doi.org/10.1038/sj.onc.1208159>
45. , V., Kučerová, D., Lišková, M., Šloncová, E., Tuháčková, Z. (1997) Changes in c-Src activity in a human colon cancer cell line during differentiation. Oncol. Rep. 4, 450-453.
46. , J. M., Gallick, G. E. (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 22, 337-358.
<https://doi.org/10.1023/A:1023772912750>
47. , J. (2000) Cancer: is there involved a bunch of culprits, one culprit, or something in between? Folia Biol. (Praha) 46, 219-225.
48. , Z., Sovová, V., Šloncová, E., Proud, C. G. (1999) Rapamycin-resistant phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in v-src-transformed fibroblasts. Int. J. Cancer 81, 963-969.
<https://doi.org/10.1002/(SICI)1097-0215(19990611)81:6<963::AID-IJC20>3.0.CO;2-C>
49. , M., Šloncová, E., Kučerová, D., Jiřička, J., Sovová, V., Tuháčková, Z. (2003) Initiation factor eIF2B not p70 S6 kinase involved in the activation of the PI-3K signalling pathway induced by the v-src oncogene. FEBS Lett. 43, 81-86.
<https://doi.org/10.1016/S0014-5793(03)00415-0>
50. , M., Tuháčková, Z., Hlaváček, J., Velek, J., Sovová, V. (2004) The v-Src and c-Src tyrosine kinases immunoprecipitated from Rous sarcoma virus transformed cells display different peptide substrate specificities. Arch. Biochem. Biophys. 421, 277-282.
<https://doi.org/10.1016/j.abb.2003.11.008>
51. , C. M., Connell, M. C., Pyne, S., Pyne, N. J. (2005) c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells. Cell. Signal. 17, 263-277.
<https://doi.org/10.1016/j.cellsig.2004.07.011>
52. , T. C., Parikh, N. U., Siwak, D. R., Summy, J. M., McConkey, D. J., Kraker, A. J., Gallick, G. E. (2002) Src activation regulates anoikis in human colon tumor cell lines. Oncogene 21, 7797-7807.
<https://doi.org/10.1038/sj.onc.1205989>
53. , B., Miller, W. T. (1996) Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain. Mol. Cell. Biochem. 158, 57-63.
<https://doi.org/10.1007/BF00225883>
54. , T. J. (2004) A renaissance for SRC. Nat. Rev. Cancer 4, 470-480.
<https://doi.org/10.1038/nrc1366>
